Analyst Ratings for Nuvectis Pharma (NVCT)
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
7/13/2022 | Ladenburg Thalmann | Aydin Huseynov | New Coverage | Buy (N/A) |
21.00 (N/A) |
12.69 (6.66) |
-47.52% | Details |
3/2/2022 | H.C. Wainwright » Updated 3/22/2022 |
Joseph Pantginis | New Coverage | Buy (N/A) |
14.00 (N/A) |
6.81 (6.66) |
-2.2% | Details |